dexamethasone 21-phosphate has been researched along with Age-Related Macular Degeneration in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guthrie, MJ; Kang-Mieler, JJ; Mieler, WF; Osswald, CR; Valio, NL | 1 |
Deligiannis, I; Echiadis, G; Giannikakis, S; Kavalarakis, E; Papaefthymiou, I; Pervena, A; Vakalis, N | 1 |
1 trial(s) available for dexamethasone 21-phosphate and Age-Related Macular Degeneration
Article | Year |
---|---|
Intravitreal combination of dexamethasone sodium phosphate and bevacizumab in the treatment of exudative AMD.
Topics: Aged; Aged, 80 and over; Angiogenesis Inhibitors; Bevacizumab; Dexamethasone; Drug Combinations; Female; Humans; Intravitreal Injections; Macular Degeneration; Male; Middle Aged; Pilot Projects; Retina; Treatment Outcome | 2015 |
1 other study(ies) available for dexamethasone 21-phosphate and Age-Related Macular Degeneration
Article | Year |
---|---|
Objective area measurement technique for choroidal neovascularization from fluorescein angiography.
Topics: Animals; Bruch Membrane; Choroidal Neovascularization; Dexamethasone; Fluorescein; Fluorescein Angiography; Humans; Hydrogels; Image Processing, Computer-Assisted; Intravitreal Injections; Lasers; Macular Degeneration; Male; Nanospheres; Rats; Rats, Long-Evans; Triamcinolone Acetonide | 2014 |